Navigation Links
Mayo Clinic Proceedings Reviews Deep Brain Stimulation to Treat Psychiatric Diseases
Date:6/29/2009

ion surgery while a neurosurgeon implants the electrodes. Patients are able to give immediate feedback. Additionally, patients do not feel any pain during the implantation procedure since the brain is without pain receptors.

In the developed world, major depression is second only to cardiovascular disease in premature mortality and time lived with disability according to the review. In persons aged 15 to 44 years, depression is the most disabling medical illness in the United States. The prevalence of major depression, known to be a chronic and relapsing illness, is approximately 17 percent, affecting almost 1 in 5 persons.

Medications and psychiatric therapy can effectively treat many patients with major depression; however, up to 20 percent of these patients fail to respond to these non-surgical therapeutic interventions.

"DBS is not a miracle cure and should not be used to treat all depression," says Dr. Lee. "It should be reserved for those patients who have treatment-resistant depression and approved by a multi-disciplinary team." Ongoing advances in DBS technologies represent an important new field that could greatly advance the understanding of psychiatric neurobiology, according to the review.

A peer-review journal, Mayo Clinic Proceedings publishes original articles and reviews dealing with clinical and laboratory medicine, clinical research, basic science research and clinical epidemiology. Mayo Clinic Proceedings is published monthly by Mayo Foundation for Medical Education and Research as part of its commitment to the medical education of physicians. The journal has been published for more than 80 years and has a circulation of 130,000 nationally and internationally. Articles are available online at www.mayoclinicproceedings.com.

VIDEO ALERT: Additional audio and video resources, including e
'/>"/>

SOURCE Mayo Clinic
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Sosei and Vectura Announce Start of Phase III Clinical Study With NVA237
2. Infant Formula Company Teams With the University of Virginia Pediatrics Department to Conduct Clinical Studies
3. Conatus Pharmaceuticals Initiates a Second Phase 2 Clinical Trial for the Treatment of Hepatitis
4. West Wireless Health Institute Teams with Corventis for its First Multicenter, Randomized Clinical Trial
5. Covance Announces Integrated Radiolabeled Clinical Pharmacology Studies
6. DIA Annual Meeting Attendees Invited to Participate in Electronic Data Capture (EDC) Clinical Trial Survey
7. Cephalon Provides Clinical Update on Lestaurtinib in Relapsed Acute Myelogenous Leukemia
8. New Safety Regulations Drive Greater Need for Resources and Expertise at Every Stage of Clinical Development
9. ProFibrix Initiates Phase II Clinical Trial of its Lead Topical Hemostat Product Fibrocaps(TM)
10. Clinical and Histopathological Results Using Pollogens TriPollar(TM) Radio Frequency Technology Published in the June Issue of the Journal of Cosmetic and Laser Therapy
11. HEALTHPOINT-Sponsored Venous Leg Ulcer Clinical Trial Enrolls First Subject for Second Phase II Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... Inc. (OTC: CSBR), engaged in the development of advanced ... use of oncology drugs, today announced its financial results ... Fourth Quarter and Recent Business Highlights: , Quarterly ... result , Procured a quarterly record high of ... Oncology CEO, stated, "The end of fiscal 2015 is ...
(Date:7/28/2015)... Mass. , July 28, 2015  Alere Inc. ... diagnostics, today announced that it will release its financial ... The Company will host a conference call beginning at ... discuss these results and provide business updates. ... the Investor Relations section of Alere,s website, or accessed ...
(Date:7/28/2015)... Ill. , July 28, 2015 Today,s ... on par with their levels of clinical excellence. Today ... Annual Meeting & Clinical Lab Expo, Sysmex is announcing ... a comprehensive and intuitive ecosystem that will help laboratories ... key areas, Sysmex aims to add even more value ...
Breaking Medicine Technology:Champions Oncology Reports Results for Quarter and Full Year Ended April 30, 2015 2Champions Oncology Reports Results for Quarter and Full Year Ended April 30, 2015 3Champions Oncology Reports Results for Quarter and Full Year Ended April 30, 2015 4Champions Oncology Reports Results for Quarter and Full Year Ended April 30, 2015 5Champions Oncology Reports Results for Quarter and Full Year Ended April 30, 2015 6Champions Oncology Reports Results for Quarter and Full Year Ended April 30, 2015 7Champions Oncology Reports Results for Quarter and Full Year Ended April 30, 2015 8Champions Oncology Reports Results for Quarter and Full Year Ended April 30, 2015 9Champions Oncology Reports Results for Quarter and Full Year Ended April 30, 2015 10Champions Oncology Reports Results for Quarter and Full Year Ended April 30, 2015 11Alere to Report Second Quarter 2015 Financial Results on August 4, 2015 2Sysmex Moves Beyond a Better Box 2Sysmex Moves Beyond a Better Box 3Sysmex Moves Beyond a Better Box 4
... year in the United States more than 138,000 people are ... account for 10 percent of the new total cancer cases ... leukemia, the survival rate has not changed in the past ... Foundation Venture Capital Group, LLC, a New Jersey Health Foundation ...
... when the PLCO trial was started, we have awaited the ... The initial report of the results of this study -- ... week in the New England Journal of Medicine have told ... offer conflicting evidence about the possibility of a prostate cancer-specific ...
Cached Medicine Technology:Foundation Venture Capital Group Invests in UMDNJ Company Working to Improve Leukemia Treatments 2A Joint Statement From America's Prostate Cancer Advocacy, Education, and Support Organizations 2A Joint Statement From America's Prostate Cancer Advocacy, Education, and Support Organizations 3
(Date:7/28/2015)... , ... July 28, 2015 , ... Egg freezing ... the procedure to help ensure future fertility. As Dr. Michael Kettel explained ... freezing is an option that wasn’t available for previous generations who had to make ...
(Date:7/28/2015)... ... July 28, 2015 , ... BMI of Texas, which specializes ... duodenal switch weight loss surgery procedure. Committed to helping patients achieve their ... BMI of Texas is one of the first practices in South Texas ...
(Date:7/28/2015)... Angeles, CA (PRWEB) , ... July 28, 2015 , ... ... highs several times a day to a few times a year. The World Health ... research study by the National Institute of Mental Health reveals that the United States ...
(Date:7/28/2015)... Fayetteville, Arkansas (PRWEB) , ... July 28, 2015 ... ... discovery company developing targeted biologics and biologic-device combination products for the treatment of ... Trademark Office issued U.S. Patent No. 9,062,300 entitled "Fusion Proteins of Collagen Binding-Domain ...
(Date:7/28/2015)... ... July 28, 2015 , ... Care ... proprietary, web based clinical knowledge system, called “Referral Guidance.” , Referral ... provides physicians who are anticipating making a subspecialty referral an efficient means to ...
Breaking Medicine News(10 mins):Health News:Dr. Michael Kettel of San Diego Fertilty Center Interviewed by the San Diego Union-Tribune on Egg Freezing 2Health News:Dr. Michael Kettel of San Diego Fertilty Center Interviewed by the San Diego Union-Tribune on Egg Freezing 3Health News:BMI of Texas Now Offering Duodenal Switch Surgery – Weight Loss Procedure Helps Obese Patients Lose Weight Quickly 2Health News:BMI of Texas Now Offering Duodenal Switch Surgery – Weight Loss Procedure Helps Obese Patients Lose Weight Quickly 3Health News:"I Am Not I" Music Video Raises Bipolar Disorder Awareness 2Health News:BiologicsMD, Inc. Announces Additional US Patent Issuance Covering Company’s Pipeline of Targeted Therapies 2Health News:Introducing Care to Care’s New Web Based “Referral Guidance” Program 2
... Over the counter (OTC) drugs can be highly addictive, warn ... ,The development of dependency on OTC drugs is often forgotten, ... past three months, they describe seeing three patients with addictions ... three had started using the product for its approved indications, ...
... cancer research study that may be the last best chance ... to discover the genetic and environmental factors that cause and ... aims to enroll a geographically and ethnically diverse group of ... pave the way for the next generation of American Cancer ...
... such as endometriosis, but it is also being proposed ... menstruation or find it inconvenient. ,But ... lifestyle choice, asks Paula Derry, a Health Psychologist in ... reduce or eliminate periods are being developed, she writes. ...
... if neglected, specialists warn. Most of us brush ... is harmless. But specialists say it could lead to chronic ... or cause harm to any part of the brain. ... because of unchecked pollution. Chronic sinus may also be caused ...
... in The American Journal of Gastroenterology suggests that smoking ... attacked in those who suffer from Crohns disease. ... patient will eventually require surgical treatment. ,In ... frequently in the small intestine, rather than the colon, ...
... Britons may just feel the heart in their mouth when they ... of suffering a heart attack have finally been identified by ... shown that one fifth of Britons carry a particular gene which ... grace could come in the form of making healthy lifestyle choices ...
Cached Medicine News:Health News:American Cancer Society Launches Major New Study 2Health News:American Cancer Society Launches Major New Study 3Health News:Should Menstrual Suppression Be a Lifestyle Choice? 2Health News:A Cold Shoulder to Cold - At Your Risk 2Health News:The DNA That Spells Double Risk of Heart Attack 2
...
... contains primers and a FAM-labeled probe that is ... 532-labeled probe to detect Flu B. In addition, ... probe for a separate sample processing control. This ... Alexa 532 and Texas Red reporter dyes such ...
...
Digital Ultrasonic Diagnostic Imaging System...
Medicine Products: